口服避孕药添加叶酸:育龄妇女增补叶酸的新途径

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (640 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要妇女孕前和孕早期增补叶酸可有效降低胎儿神经管缺陷及其他出生缺陷的发生风险。目前的叶酸增补方法包括叶酸主食强化、服用叶酸增补剂等。近年来,国际上提出了口服避孕药添加叶酸的叶酸增补新思路。尽管我国推行免费发放叶酸项目后,叶酸增补率大幅度提高,但是还存在着服用最佳时间不恰当,从孕前开始增补比例低等问题。对于不宜或不愿采取长效宫内节育器避孕的妇女、暂时不打算生育、同时有避孕要求和停药后立即有生育要求的育龄妇女而言,使用添加叶酸成分的口服避孕药,有助于保证体内有较高水平的叶酸储备,降低胎儿畸形的风险,同时对妇女自身的健康也有益。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	刘菊芬
	任爱国

关键词 ：口服避孕药, 叶酸, 育龄妇女, 神经管缺陷

收稿日期: 2014-11-14

基金资助:国家自然科学基金(81202265)

通讯作者: 任爱国(renag@pku.edu.cn)

引用本文:

刘菊芬, 任爱国. 口服避孕药添加叶酸:育龄妇女增补叶酸的新途径[J]. 中国生育健康杂志, 2015, 26(2): 181-183.

链接本文:

http://cjrh.bjmu.edu.cn/CN/ 或 http://cjrh.bjmu.edu.cn/CN/Y2015/V26/I2/181

1 Berry RJ,Li Z,Erickson JD,et al.Prevention of neural-tube defects with folic acid in China.China-U.S.Collaborative Project for Neural Tube Defect Prevention.N Engl J Med,1999,341:1485-1490.
2 Czeizel AE,Dudas I.Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation.N Engl J Med,1992,327:1832-1835.
3 MRC Vitamin Study Research Group.Prevention of neural tube defects:results of the Medical Research Council Vitamin Study.Lancet,1991,338:131-137.
4 Gardiner HM,Fouron JC.Folic acid fortification and congenital heart disease.BMJ,2009,338:b1144.
5 Houston M.Taking folic acid at start of pregnancy seems to lower risk of cleft lip and palate.BMJ,2012,345:e4614.
6 Centers for Disease Control.Use of folic acid for prevention of spina bifida and other neural tube defects--1983-1991.MMWR Morb Mortal Wkly Rep,1991,40:513-516.
7 Van Allen MI,Fraser FC,Dallaire L,et al.Recommendations on the use of folic acid supplementation to prevent the recurrence of neural tube defects.Clinical Teratology Committee,Canadian College of Medical Geneticists.CMAJ,1993,149:1239-1243.
8 Rasmussen LB,Andersen NL,Andersson G,et al.Folate and neural tube defects.Recommendations from a Danish working group.Dan Med Bull,1998,45:213-217.
9 Bower C,Blum L,O’Daly K,et al.Promotion of folate for the prevention of neural tube defects:knowledge and use of periconceptional folic acid supplements in western Australia,1992 to 1995,Aust N Z J Public Health,1997,21:726-721.
10 Centers for Disease Control.Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects.MMWR Recomm Rep,1992,41:1-7.
11 李竹,严仁英,秦新华,等.论在我国推广“妇女增补叶酸预防神经管畸形”成果的必要性和适时性.中国优生优育,1994,5:33-37.
12 Wald NJ.Folic acid and the prevention of neural-tube defects.N Engl J Med,2004,350:101-103.
13 WHO.Standards for maternal and neonatal care.[2014-12-04].http://www.who.int/reproductivehealth/publications/maternal_perinatal_health/neural_tube_defects.pdf?ua=1.
14 任爱国.叶酸预防神经管缺陷.北京大学学报(医学版),2014,46:343-346.
15 卫生部.增补叶酸预防神经管缺陷项目管理方案.2009.
16 Liu J,Jin L,Meng Q,et al.Changes in folic acid supplementation behaviour among women of reproductive age after the implementation of a massive supplementation programme in China.Public Health Nutr,2014:1-7.
17 United Nations,Department of Economic and Social Affairs,Population Division.World Contraceptive Use 2012 (POP/DB/CP/Rev2012).2012.
18 黄婷,曾佳,曹云峰,等.2007-2011年美国FDA批准上市的复方口服避孕药概况.中国新药与临床杂志,2012,31:498-504.
19 Shojania AM,Hornady G,Barnes PH.Oral contraceptives and serum-folate level.Lancet,1968,1:1376-1377.
20 Paton A.Oral contraceptives and folate deficiency.Lancet,1969,1:418.
21 Shojania AM,Hornady G,Barnes PH.Oral contraceptives and folate metabolism.Lancet,1969,1:886.
22 Ahmed F,Bamji MS,Iyengar L.Effect of oral contraceptive agents on vitamin nutrition status.Am J Clin Nutr,1975,28:606-615.
23 Green TJ,Houghton LA,Donovan U,et al.Oral contraceptives did not affect biochemical folate indexes and homocysteine concentrations in adolescent females.J Am Diet Assoc,1998,98:49-55.24 McArthur JO,Tang H,Petocz P,et al.Biological variability and impact of oral contraceptives on vitamins B(6),B(12) and folate status in women of reproductive age.Nutrients,2013,5:3634-3645.
25 Meguid MM,Loebl WY.Megaloblastic anaemia associated with the oral contraceptive pill.Postgrad Med J,1974,50:470-472.
26 Davis AR,Kroll R,Soltes B,et al.Occurrence of menses or pregnancy after cessation of a continuous oral contraceptive.Fertil Steril,2008,89:1059-1063.
27 Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs and World Health Organization.Family planning:a global handbook forproviders 2011 Update.2011:22.
28 Fruzzetti F.Beyaz(R):an oral contraceptive fortified with folate.Womens Health (Lond Engl),2012,8:13-19.
29 Castano PM,Aydemir A,Sampson-Landers C,et al.The folate status of reproductive-aged women in a randomised trial of a folate-fortified oral contraceptive:dietary and blood assessments.Public Health Nutr,2014,17:1375-1383.
30 Daly LE,Kirke PN,Molloy A,et al.Folate levels and neural tube defects.Implications for prevention.JAMA,1995,274:1698-1702.
31 van Eijsden M,Smits LJ,van der Wal MF,et al.Association between short interpregnancy intervals and term birth weight:the role of folate depletion.Am J Clin Nutr,2008,88:147-153.
32 Holzgreve W,Pietrzik K,Koletzko B,et al.Adding folate to the contraceptive pill:a new concept for the prevention of neural tube defects.J Matern Fetal Neonatal Med,2012,25:1529-1536.
33 Barnhart KT,Schreiber CA.Return to fertility following discontinuation of oral contraceptives.Fertil Steril,2009,91:659-663.
34 Cronin M,Schellschmidt I,Dinger J.Rate of pregnancy after using drospirenone and other progestin-containing oral contraceptives.Obstet Gynecol,2009,114:616-622.
35 吴尚纯,邱红燕.中国人工流产的现状与对策建议.中国医学科学院学报,2010,32:479-482.
36 张亚黎,罗宝蓉,李宏田,等.北京地区非医学原因人工流产现状调查.中华医学杂志,2014,94:2304-2307.